Related Experiment Video
Updated: Aug 13, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
The central region of HDM2 provides a second binding site for p53
Grace W Yu1, Stefan Rudiger, Dmitry Veprintsev
1Centre for Protein Engineering, Medical Research Council, Hills Road, Cambridge CB2 2QH, United Kingdom.
Abstract:
HDM2 is a negative regulator of p53 that inhibits its transcriptional activity and subjects it to degradation by an E3 ligase activity. The primary binding site for HDM2 on p53 is located in its N-terminal domain. A second site on the p53 core domain (p53C) binds to an unidentified site in HDM2. We found that this site is in its acidic domain and part of the zinc finger domain by examining the interaction of full-length and domain constructs of p53 with the N-terminal region of HDM2 and peptide arrays derived from the full-length protein. NMR spectroscopy showed that peptides derived from this region of HDM2 bound to residues in the specific DNA-binding site of p53C. The peptides were displaced from the site by gadd45 sequence-specific DNA. Phosphorylation of single amino acids in the central domain of HDM2 did not abolish the interaction between the HDM2-derived peptides and p53C. We speculate that this second binding site helps in stabilizing the interaction between HDM2 and p53 during p53 degradation.
Insights
HDM2 negatively regulates p53. Researchers identified a second binding site on p53
Area of Science:
- Molecular Biology
- Protein-Protein Interactions
- Cancer Biology
Background:
- HDM2 (Human Double Minute 2) is a key negative regulator of the tumor suppressor p53.
- HDM2 inhibits p53 transcriptional activity and promotes its degradation via E3 ligase activity.
- The primary HDM2 binding site on p53 is in its N-terminal domain.
Purpose of the Study:
- To identify the previously unknown second binding site of HDM2 on the p53 core domain (p53C).
- To characterize the nature of this secondary interaction and its functional implications.
Main Methods:
- Interaction studies using full-length and domain constructs of p53.
- Peptide array analysis of HDM2-derived peptides.
- Nuclear Magnetic Resonance (NMR) spectroscopy to determine binding sites.
- Competition assays with gadd45 DNA.
Main Results:
- The second binding site for HDM2 on p53C was mapped to HDM2's acidic and zinc finger domains.
- NMR revealed that HDM2 peptides bind to the DNA-binding site of p53C.
- This HDM2 binding site is distinct from the p53 DNA binding site and can be displaced by gadd45 DNA.
- Phosphorylation of HDM2 did not disrupt this secondary interaction.
Conclusions:
- A second, functionally relevant binding site between HDM2 and p53C was identified within the acidic and zinc finger domains of HDM2.
- This interaction occurs at the p53 DNA-binding site and may stabilize the HDM2-p53 complex, facilitating p53 degradation.
- Understanding this secondary interaction offers new insights into p53 regulation and potential therapeutic strategies.
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Histone Variants at the Centromere
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules

